Macrogenics Inc (MGNX) Stock: A Look at the Monthly Trend

5d ago, source: newsheater

In summary, Macrogenics Inc (MGNX) has had a better performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note ...

Buy Rating Affirmed for MacroGenics on Strong Oncology Pipeline and Positive Phase II Trial Results

5d ago, source:

Mayank Mamtani, an analyst from B.Riley Financial, has initiated a new Buy rating on MacroGenics (MGNX). Mayank Mamtani has given his Buy ...

Incyte Reports 2024 First Quarter Financial Results and Provides Updates on Key Clinical Programs

20h ago, source:

Incyte to acquire Escient Pharmaceuticals and its pipeline of first-in-class oral MRGPR antagonists with the potential to ...

Stock Market Today: Google surge powers tech as markets eye inflation data

on MSN ago, source:

Stocks are on pace for a modestly weekly gain ahead of a key March inflation report prior to the opening bell.

Snap upgraded, Apple downgraded: Wall Street's top analyst calls

4d ago, source: The Fly on MSN

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research ...

Stocks Push Higher on Strength in Chip Stocks and Lower Bond Yields

26d ago, source:

Celanese ( CE) is down more than -1% after JPMorgan Chase downgraded the stock to underweight from neutral with a price target of $160. Hertz Global Holdings ( HTZ) is down more than -5% after Goldman ...

Acrivon Therapeutics: Strong Buy Recommendation on Impressive AP3 Platform and ACR-368 Data Validation

6d ago, source:

Analyst Silvan Tuerkcan of JMP Securities maintained a Buy rating on Acrivon Therapeutics, Inc. (ACRV – Research Report), boosting the ...

Astellas Pharma gets grant for antibodies for diagnosing cancer by detecting cldn6 expression

6d ago, source: Pharmaceutical Technology

Discover how Astellas Pharma's patent for antibodies targeting CLDN6 revolutionizes cancer diagnosis and treatment. Learn about the specific amino acid sequences and potential applications in this ...

Gastric Cancer Drug Pipeline Research 2024: Significant Advancements and Numerous Therapies with Over 200 in Development

7d ago, source:

The "Gastric Cancer - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering.The latest insights into the Gastric Cancer pipeline have revealed over 180 companies are ...

Harness Therapeutics appoints experienced biopharma exec as Chair

6d ago, source: Business Weekly

Experienced biopharma executive Meenu Chhabra Karson has been appointed Chair of the Board at Cambridge-based Harness ...